AVE avecho biotechnology limited

poh shareholder meeting, page-9

  1. 694 Posts.
    lightbulb Created with Sketch. 167
    Thanks for the post GC.

    Re: OxyC

    I thought the announcement last week meant we are going back to the clinic for a multi dosing trial...apparently not.

    My (wrong), impression was that the clinical trial in Feb 2012,(single dose?), was meant to pave the way for finalization of the patch design and the next trial would be multi dosing.

    I don't have any issues with the delay as I'm 100% for POH dotting all their i's and crossing all their t's before heading into the home straight.

    It's great to read the positivity within your post. IMO if things go to plan there is plenty of upside with the potential for some large lumps of upside within the next 6 months.




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $14.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $14.25K 3.133M

Buyers (Bids)

No. Vol. Price($)
27 19216670 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28454159 24
View Market Depth
Last trade - 15.09pm 22/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.